Management of rheumatic disease with comorbid HBV or HCV infection

Systematic Review: The Effect of Preventive Lamivudine on Hepatitis B Reactivation during Chemotherapy

(2013) Rohit Loomba et al.   ANNALS OF INTERNAL MEDICINE

Review article: current antiviral therapy of chronic hepatitis B

(2011) W. S. Ayoub et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Editorial: Staging Liver Fibrosis in Hepatitis C: A Challenge for This Decade

(2011) Michelle Lai et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis

(2011) Yu Xuan Koo et al.   ANNALS OF HEMATOLOGY

Let the fog be lifted: screening for hepatitis B virus before biological therapy

(2011) K. L. Winthrop et al.   ANNALS OF THE RHEUMATIC DISEASES

Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy

(2011) J.-L. Lan et al.   ANNALS OF THE RHEUMATIC DISEASES

A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis

(2011) Michael C. Sneller et al.   ARTHRITIS AND RHEUMATISM

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

(2011) S. De Vita et al.   ARTHRITIS AND RHEUMATISM

Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients

(2011) Maurizio Pietrogrande et al.   AUTOIMMUNITY REVIEWS

Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? Yes

(2011) Dimitrios Vassilopoulos   European Journal of Internal Medicine

Natural history of chronic hepatitis B in Euro-Mediterranean and African Countries

(2011) Stephanos J. Hadziyannis   JOURNAL OF HEPATOLOGY

The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*

(2011) A. Hatzakis et al.   JOURNAL OF VIRAL HEPATITIS

The cryoglobulinaemias

(2011) Manuel Ramos-Casals et al.   LANCET

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

(2011) Markus Cornberg et al.   LIVER INTERNATIONAL

Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted Therapy

(2011) Roberto Pérez-Alvarez et al.   MEDICINE

A patient with rheumatoid arthritis treated with tocilizumab together with lamivudine prophylaxis after remission of infliximab-reactivated hepatitis B

(2011) Hideki Tsuboi et al.   Modern Rheumatology

Introduction: A smouldering public-health crisis

(2011) Lauren Gravitz   NATURE

A New Era of Hepatitis C Therapy Begins

(2011) Donald M. Jensen   NEW ENGLAND JOURNAL OF MEDICINE

Chronic Hepatitis C Infection

(2011) Hugo R. Rosen   NEW ENGLAND JOURNAL OF MEDICINE

Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis

(2011) David Saadoun et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review

(2011) A. M. G. Brunasso et al.   RHEUMATOLOGY

Emerging Viral Infections in Rheumatic Diseases

(2011) Atul A. Khasnis et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports

(2010) A. M. Evens et al.   ANNALS OF ONCOLOGY

Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection

(2010) D. Vassilopoulos et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease

(2010) A. Petrarca et al.   BLOOD

Pegylated interferon- , ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study

(2010) F. Dammacco et al.   BLOOD

Rituximab plus Peg-interferon- /ribavirin compared with Peg-interferon- /ribavirin in hepatitis C-related mixed cryoglobulinemia

(2010) D. Saadoun et al.   BLOOD

Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma

(2010) Kosei Matsue et al.   CANCER

Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B

(2010) E. Jenny Heathcote et al.   GASTROENTEROLOGY

The natural history of chronic hepatitis B virus infection

(2010) Brian J. McMahon   HEPATOLOGY

Hepatitis B: The virus and disease

(2010) T. Jake Liang   HEPATOLOGY

Reactivation of hepatitis B

(2010) Jay H. Hoofnagle   HEPATOLOGY

Prospective Analysis of Hepatitis B Virus Reactivation in Patients With Diffuse Large B-Cell Lymphoma After Rituximab Combination Chemotherapy

(2010) Nozomi Niitsu et al.   JOURNAL OF CLINICAL ONCOLOGY

Endpoints of hepatitis B treatment

(2010) W. Chotiyaputta et al.   JOURNAL OF VIRAL HEPATITIS

Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy

(2010) Jorge Méndez-Navarro et al.   LIVER INTERNATIONAL

Successful tocilizumab treatment in a patient with adult-onset Still’s disease complicated by chronic active hepatitis B and amyloid A amyloidosis

(2010) Dai Kishida et al.   Modern Rheumatology

Pathogenesis of hepatitis B virus infection

(2010) F.V. Chisari et al.   PATHOLOGIE BIOLOGIE

Safety of tumor necrosis factor α blockers in hepatitis B virus occult carriers (hepatitis B surface antigen negative/anti-hepatitis B core antigen positive) with rheumatic diseases

(2010) R. Caporali et al.   ARTHRITIS CARE & RESEARCH

Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients

(2009) Sung-Nan Pei et al.   ANNALS OF HEMATOLOGY

Rituximab may form a complex with iGmκ mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus–induced vasculitis

(2009) Damien Sène et al.   ARTHRITIS AND RHEUMATISM

Rheumatic manifestations of hepatitis

(2009) Dimitrios Vassilopoulos et al.   CURRENT OPINION IN RHEUMATOLOGY

Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection

(2009) Marianna Hösel et al.   HEPATOLOGY

Outcomes of a Hepatitis C Screening Program at a Large Urban VA Medical Center

(2009) Holly Groom et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis

(2009) Athina Pyrpasopoulou et al.   RHEUMATOLOGY INTERNATIONAL

Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients

(2009) Caroline Charpin et al.   ARTHRITIS RESEARCH & THERAPY

Analysis of reactivation of hepatitis B virus in the treatment of B cell non-Hodgkin’s lymphoma in Hokkaido

(2008) Yutaka Tsutsumi et al.   ANNALS OF HEMATOLOGY

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma

(2008) Yi-Fu He et al.   ANNALS OF HEMATOLOGY

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

(2008) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis

(2008) D. Saadoun et al.   BLOOD

Diagnosis and Quantitation of Fibrosis

(2008) Diarmuid S. Manning et al.   GASTROENTEROLOGY

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY

Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

(2008) Winnie Yeo et al.   JOURNAL OF CLINICAL ONCOLOGY

Statements from the Taormina expert meeting on occult hepatitis B virus infection

(2008) Giovanni Raimondo et al.   JOURNAL OF HEPATOLOGY

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

(2008)   JOURNAL OF HEPATOLOGY

Hepatitis B Virus Infection

(2008) Jules L. Dienstag   NEW ENGLAND JOURNAL OF MEDICINE

Long-term tocilizumab therapy in a patient with rheumatoid arthritis and chronic hepatitis B

(2008) T. Nagashima et al.   RHEUMATOLOGY